Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

CSF abnormalities can be predicted by VEP and MRI pathology in the examination of optic neuritis.
Diffusion tensor imaging based network analysis detects alterations of neuroconnectivity in patients with clinically early relapsing-remitting multiple sclerosis.
Sexual dysfunction in multiple sclerosis: A 6-year follow-up study.
Lymphocytosis as a response biomarker of natalizumab therapeutic efficacy in multiple sclerosis.
Rituximab, B-lymphocyte depletion, and preservation of beta-cell function.
Assessment of immune functions and MRI disease activity in relapsing-remitting multiple sclerosis patients switching from natalizumab to fingolimod (ToFingo-Successor).
Cortical Pathology in RRMS: Taking a Cue from Four Sisters.
Identification of Risk Factors for Falls in Multiple Sclerosis: A Systematic Review and Meta-Analysis.
A novel data mining system points out hidden relationships between immunological markers in multiple sclerosis.
A case of prolonged delayed postdural puncture headache in a patient with multiple sclerosis exacerbated by air travel.
Nanowire-mediated delivery enables functional interrogation of primary immune cells: application to the analysis of chronic lymphocytic leukemia.
Impact of multiple sclerosis relapses on progression diminishes with time.
Protective Role of (RS )-glucoraphanin Bioactivated with Myrosinase in an Experimental Model of Multiple Sclerosis.
Bilateral Vision Loss Responsive to Corticosteroids.
XY sex chromosome complement, compared with XX, in the CNS confers greater neurodegeneration during experimental autoimmune encephalomyelitis
Torque teno mini virus infection and multiple sclerosis.
Effect of autoimmune diseases on risk and survival in female cancers.
Autophagy in immunity: Implications in etiology of autoimmune/autoinflammatory diseases.
Role of early viral infections in development of multiple sclerosis.
The impact of osteopontin gene variations on multiple sclerosis development and progression.
Ipilimumab Therapy in Patients With Advanced Melanoma and Preexisting Autoimmune Disorders.
CD8(+) T cells in multiple sclerosis.
Risk genes associated with pediatric-onset MS but not with monophasic acquired CNS demyelination.
Alemtuzumab (LEMTRADA) and multiple sclerosis. Biased evaluation, evidence of serious risks.
Longitudinal association between depressive symptoms and walking impairment in people with relapsing-remitting multiple sclerosis.

Pages